Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.
about
Dosimetrically administered nebulized morphine for breathlessness in very severe chronic obstructive pulmonary disease: a randomized, controlled trial.The Trends in Cardiovascular Diseases and Respiratory Diseases Mortality in Urban and Rural China, 1990-2015.The Unmet Needs of People with Chronic Obstructive Pulmonary Disease: A Systematic Review of Qualitative Findings.Pharmacoeconomic Analysis of Drugs Used in the Treatment of Pneumonia in Paediatric Population in a Tertiary Care Hospital in India-A Cost-of-Illness Study.Asthma and Allergic Disorders in Uganda: A Population-Based Study Across Urban and Rural Settings.Regional, age and respiratory-secretion-specific prevalence of respiratory viruses associated with asthma exacerbation: a literature review.Defining the relationship between COPD and CVD: what are the implications for clinical practice?Factors Associated with Cigarette Smoking and Motivation to Quit among Street Food Sellers in Vietnam.Burden of COPD in Nepal.Cost-effectiveness of FreeO2 in patients with chronic obstructive pulmonary disease hospitalised for acute exacerbations: analysis of a pilot study in Quebec.Extracorporeal carbon dioxide removal in acute exacerbations of chronic obstructive pulmonary disease.Need of support in people with chronic obstructive pulmonary disease.Geographical distribution of COPD prevalence in Europe, estimated by an inverse distance weighting interpolation technique.Randomized, double-blind, placebo-controlled trial to assess the efficacy and safety of three doses of co-suspension delivery technology glycopyrronium MDI in Japanese patients with moderate-to-severe COPD.Trends in asthma hospital admissions and mortality in Kuwait, 2000-2014: a national retrospective observational study.Influence of the Scandinavian climate pattern on the UK asthma mortality: a time series and geospatial study.The association between airway eosinophilic inflammation and IL-33 in stable non-atopic COPD.Cost-effectiveness of umeclidinium compared with tiotropium and glycopyrronium as monotherapy for chronic obstructive pulmonary disease: a UK perspective.The Role of the Immune Response in the Pathogenesis of Bronchiectasis.Association of epilepsy and asthma: a population-based retrospective cohort study.Socioeconomic and Environmental Predictors of Asthma-Related Mortality.Prediction of severe exacerbations and mortality in COPD: the role of exacerbation history and inspiratory capacity/total lung capacity ratio.Efficacy and safety of four doses of glycopyrrolate/formoterol fumarate delivered via a metered dose inhaler compared with the monocomponents in patients with moderate-to-severe COPD.High Prevalence of Asthma in Elderly Women: Findings From a Korean National Health Database and Adult Asthma Cohort.Improved lung function and quality of life following guaifenesin treatment in a patient with chronic obstructive pulmonary disease (COPD): A case report.Does the GOLD 2017 Classification Improve the Ability to Predict Exacerbation and Mortality?Anti-Allergic Inflammatory Activity of Interleukin-37 Is Mediated by Novel Signaling Cascades in Human Eosinophils.The Burden of Pediatric Asthma.Validation of the Saint George’s Respiratory Questionnaire in Uganda.Does pulmonary rehabilitation alter patients' experiences of living with chronic respiratory disease? A qualitative studyInternational research and guidelines on post-tuberculosis chronic lung disorders: a systematic scoping reviewProton pump inhibitors use is associated with a lower risk of acute exacerbation and mortality in patients with coexistent COPD and GERDChanging patterns of adult asthma incidence: results from the National Health Insurance Service-National Sample Cohort (NHIS-NSC) database in KoreaImproved lung function and patient-reported outcomes with co-suspension delivery technology glycopyrrolate/formoterol fumarate metered dose inhaler in COPD: a randomized Phase III study conducted in Asia, Europe, and the USAEffectiveness-implementation of COPD case finding and self-management action plans in low- and middle-income countries: global excellence in COPD outcomes (GECo) study protocolEosinophil counts in first COPD hospitalizations: a 1-year cost analysis in Quebec, CanadaWhich eHealth interventions are most effective for smoking cessation? A systematic reviewThe prevalence, burden and risk factors associated with bronchial asthma in commonwealth of independent states countries (Ukraine, Kazakhstan and Azerbaijan): results of the CORE studyA systematic review of associations between non-communicable diseases and socioeconomic status within low- and lower-middle-income countriesToward effective prescription of inhaled corticosteroids in chronic airway disease
P2860
Q47104056-75F1CE3B-6874-4883-BBD3-149F6EF8A34FQ47110585-05947264-4F77-4329-9B75-2CC896B36687Q47178619-7577F25D-E57D-4986-81AB-CEB85EEBA4B5Q47214223-60CC6986-7F4B-46D4-8B9A-57F9995647BEQ47549918-495989CB-9B2C-42A9-9DC0-1AEA8547AB05Q47554686-0F47FCC3-B812-40C4-A274-D634028D5D88Q47651592-03CA10DD-C118-44F3-8B62-519E15B6EF20Q48140507-F6920E49-E8E6-4C8A-A43B-9DB050A3D2D4Q49618500-3B8C894B-ECB4-4CA0-AF39-DD8F66E54662Q49700338-E0A4034A-49B3-4BC9-AFEA-2DBA652B304BQ49740070-6E078CCF-CC03-4CB2-BB7C-FF47DBFED8A6Q49920553-8E4A1CCC-E173-4686-A0C4-26A80D6EC4C6Q50112050-DC45859C-8A68-49DE-ACC9-0CCB72F5C0D2Q52562726-85C07654-1B43-48B6-9186-309599AF9706Q53824238-B07E3E20-B91A-44F0-A733-112DADAEFD71Q53830317-EB6A727A-DCD2-48F7-8883-02E5140C9EE2Q55007014-E61AA384-BD7A-4C70-9085-328FCBA64C6DQ55020515-8B997325-D2FA-4B29-969D-388CF2EB28DFQ55029817-0DD36F71-9B23-46BA-B53D-62701636B016Q55035770-892DCE90-D098-4B5D-856E-76DDBE06C329Q55117422-F1C0CE8C-FF3C-4EE1-8333-9F811C98FC0AQ55303818-98970F2C-8CED-4D54-BF27-09011DDBA2DCQ55364939-C6E3C372-02F5-4BF1-B0D8-B0BE2AEFEE87Q55395145-205DC6D2-2CDF-4241-AE10-E4DE97C8B40EQ55423496-FCBD2646-FF85-427B-898B-B3206D0BBAD1Q55449558-9FAD9ED5-35ED-4900-A1DA-8EF5442ECA06Q55514829-C89528E1-1289-4B33-9069-F0D19E42D0E0Q55514850-125AFB92-3094-4BCF-963A-1966B085C84AQ55689362-D587DF7E-5443-48BA-9A61-BBFE9B407EB8Q56910659-A690A46D-F4CC-4900-9EC0-A81C955F09ECQ56911167-CDBA51CF-66C9-46AC-8E5B-1DC90F1BF61CQ57073292-F643216B-2C49-4880-8BC2-69A1218F327DQ57292382-F11366E7-10A0-40AD-81D9-8C0FEEC597E5Q57491724-C97E3C05-87FF-46A2-81D3-12177EFEA9D7Q57811771-02137008-9652-423E-A5F9-336E3F042CE2Q57817679-A1E80D85-6D3E-45C1-9F33-8EE5A04AFC83Q57817714-0A8FC002-8522-4CC7-A7DE-01C7E51E098AQ57930351-8F5A869D-7791-4BFF-9434-107F153926B1Q57937347-9E6AA4BC-ADAC-46A7-84EC-36C530CF7B26Q58694610-0E62C292-E45E-48AC-A000-90236A55F57D
P2860
Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Global, regional, and national ...... Burden of Disease Study 2015.
@en
type
label
Global, regional, and national ...... Burden of Disease Study 2015.
@en
prefLabel
Global, regional, and national ...... Burden of Disease Study 2015.
@en
P2860
P1476
Global, regional, and national ...... l Burden of Disease Study 2015
@en
P2093
GBD 2015 Chronic Respiratory Disease Collaborators
P2860
P304
P356
10.1016/S2213-2600(17)30293-X
P50
P577
2017-08-16T00:00:00Z